Guangzhou Baiyunshan Pharmaceutical Co., Ltd. · 66-40 · CHINA
For Guangzhou Baiyunshan Pharmaceutical Co., Ltd. · 66-40 · CHINA, import alert is 66-40; import alert name is "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"; country is CHINA; product code is 55 - - - -- Pharm Necess & Ctnr For Drug/Bio | 56 - - - -- Antibiotics (Human/Animal) | 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs | 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs; date published is 10/25/2017; address is No. 52 Xiaogang Dama Road , Baiyun , Guangzhou, Guangdong CHINA, verified against its source on 2026-09-16.
- Firm
- Guangzhou Baiyunshan Pharmaceutical Co., Ltd. verified
- Import alert
- 66-40
- Import alert name
- "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
- Country
- CHINA verified
- Address
- No. 52 Xiaogang Dama Road , Baiyun , Guangzhou, Guangdong CHINA verified
- Date published
- 10/25/2017 verified
- Product code
- 55 - - - -- Pharm Necess & Ctnr For Drug/Bio | 56 - - - -- Antibiotics (Human/Animal) | 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs | 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs each item verified
- FDA notes
- Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices | Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices each item verified
What the source says
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Date Published : 10/25/2017 No. 52 Xiaogang Dama Road , Baiyun , Guangzhou, Guangdong CHINA 55 - - - -- Pharm Necess & Ctnr For Drug/Bio Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 56 - - - -- Antibiotics (Human/Animal) Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs Date Published: 05/26/2022 60 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 61 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 62 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 63 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 64 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 65 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices 66 - - - -- Human and Animal Drugs Date Published: 10/25/2017 Notes: Add Drugs and Drug Products;Problem(s): (GMP) Good Manufacturing Practices
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_189.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.